Related Experiment Video
Updated: Dec 10, 2025

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Periprocedural Predictors of New-Onset Conduction Abnormalities After Transcatheter Aortic Valve Replacement
Kensuke Matsushita1,2, Mohamad Kanso1, Mickael Ohana3
1Université de Strasbourg, Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire.
Insights
New conduction abnormalities after TAVR increase mortality risk. Membranous septal length and implantation depth difference (∆MSID) predict these events, guiding future TAVR procedures.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- New-onset conduction abnormalities (CAs) after transcatheter aortic valve replacement (TAVR) are linked to increased hospital readmissions and mortality.
- Predictors for these CAs, including new-onset left bundle branch block (LBBB) and permanent pacemaker (PPM) implantation, are not well-established.
Purpose of the Study:
- To identify clinical predictors of new-onset LBBB and new PPM implantation in patients undergoing TAVR.
- To investigate the association between CAs and adverse clinical outcomes post-TAVR.
Main Methods:
- A prospective registry enrolled 290 patients undergoing TAVR with SAPIEN 3 or Evolut R valves.
- Computed tomography was used to assess membranous septal anatomy and implantation depth.
- Multivariate analysis identified predictors of CAs and their association with clinical events.
Main Results:
- Among 242 patients without pre-existing LBBB, 114 (47%) developed new-onset LBBB and/or required new PPM implantation.
- A difference between membranous septal length and implantation depth (∆MSID) was the sole predictor for CAs with both valve types.
- PR interval and ∆MSID were the only predictors in multivariate analysis. Patients with CAs had a significantly higher risk of adverse clinical events (HR: 2.10; P=0.004).
Conclusions:
- Computed tomography assessment of membranous septal anatomy and implantation depth can predict CAs following TAVR with new-generation valves.
- Further research is needed to determine if adjusting implantation depth can mitigate the risk of CAs and adverse outcomes.
Background:
New-onset conduction abnormalities (CAs) following transcatheter aortic valve replacement (TAVR) are associated with hospital rehospitalization and long-term mortality, but available predictors are sparse. This study sought to determine clinical predictors of new-onset left bundle branch block (LBBB) and new permanent pacemaker (PPM) implantation in patients undergoing TAVR.
Methods And Results:
We enrolled 290 patients who received SAPIEN 3 (Edwards Lifesciences, Irvine, CA, USA; n=217) or Evolut R (Medtronic, Minneapolis, MN, USA; n=73) from a prospective registry at Nouvel Hôpital Civil, Strasbourg, France between September 2014 and February 2018. Of 242 patients without pre-existing LBBB, 114 (47%) experienced new-onset LBBB and/or new PPM implantation. A difference between membranous septal length and implantation depth (∆MSID) was the only predictor of CAs for both types of valves. In the multivariate analysis, PR interval and ∆MSID remained as sole predictors of CAs. The risk for adverse clinical events, including all-cause death, myocardial infarction, stroke, and heart failure hospitalization, was higher for patients with CAs as compared with patients without CAs (hazard ratio: 2.10; 95% confidence interval: 1.26 to 3.57; P=0.004).
Conclusions:
Computed tomography assessment of membranous septal anatomy and implantation depth predicted CAs after TAVR with new-generation valves. Future studies are required to identify whether adjustment of the implantation depth can reduce the risk of CAs and adverse clinical outcomes.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Aortic Regurgitation I: Introduction
Cardiac Catheterization IV: Nursing Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Aneurysm IV: Nursing Management

